Cardiovascular diseases imposed an overall economic burden of 8,950,000 Rials per patient, including 7,000,000 Rials in direct treatment costs.
Cross-Sectional (n=100)
Yes
Cardiovascular diseases impose a heavy economic burden on Iran's health system, with an estimated total cost of 8,950,000 Rials per patient.
Background: Cardiovascular diseases (CVDs) are one of the leading causes of death and disability worldwide and in Iran. These diseases impose a heavy economic burden on the country’s health and economic system. Objectives: The present study aimed to estimate the economic burden of CVDs in Iran. Methods: This descriptive-analytical study was conducted with data from the year 2024. This study aimed to estimate the economic burden of CVDs in Iran using data from 100 patients referred to public hospitals in Abadan. This cross-sectional study was conducted on 100 patients diagnosed with CVDs who were referred to public hospitals in Abadan, Iran, during 2023. The research sample included cardiovascular patients at Abadan University of Medical Sciences, and the study population encompassed all cardiovascular patients in the country. Cost data were collected from hospital information systems and analyzed using Excel. Direct treatment costs included hospitalization, surgeries, medications, tests, and other medical services. Non-treatment direct costs included travel expenses, lost time, and home nursing care. Indirect costs included losses due to reduced productivity and absenteeism of patients and their caregivers. The overall economic burden of CVDs was estimated based on the per capita cost for each patient and the prevalence of the disease in the country. Results: The results showed that the average direct treatment costs of CVDs were 7,000,000 Rials, non-treatment direct costs were 650,000 Rials, and indirect costs were 1,300,000 Rials per patient. The overall economic burden of CVDs per patient was estimated to be 8,950,000 Rials. Data analysis showed that direct and indirect costs were higher in older patients and those with more complex diseases. Gender differences in CVD costs were also observed, with costs varying between men and women. Conclusions: The results of this study indicate the heavy economic burden of CVDs on Iran’s health and economic system, highlighting the importance of adopting appropriate measures to reduce this economic burden. These findings can assist policymakers and healthcare managers in designing and implementing better programs for managing CVDs.
Moradi-Joo et al. (Fri,) conducted a cross-sectional in Cardiovascular diseases (n=100). Cardiovascular diseases was evaluated on Overall economic burden per patient. Cardiovascular diseases imposed an overall economic burden of 8,950,000 Rials per patient, including 7,000,000 Rials in direct treatment costs.